J.‐F. Yale
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Management and Research 6
- Diabetes Treatment and Management 4
- Diabetes Management and Education 1
- Genetics 4
- Diabetes and associated disorders 4
- Co-authors
- Hertzel C. Gerstein (5 shared papers)Ewa Wajs (2 shared papers)Dennis K. Yue (2 shared papers)Elias David‐Neto (2 shared papers)Keith Usiskin (2 shared papers)Bertrand Cariou (2 shared papers)Gary Meininger (2 shared papers)George L. Bakris (1 shared paper)
- Journals
- Diabetes Obesity and Metabolism (4 papers)Diabetic Medicine (3 papers)Diabetes (3 papers)Diabetes & Metabolism (2 papers)Diabetes Care (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
J.‐F. Yale
19 papers receiving 1.7k citations
J.‐F. Yale's Hit Papers
Peers
Comparison fields: 5 of 100
- Endocrinology, Diabetes and Metabolism 1.1k
- Nephrology 107
- Transplantation 31
- Pharmacology 140
- Obstetrics and Gynecology 54
Countries citing papers authored by J.‐F. Yale
This map shows the geographic impact of J.‐F. Yale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.‐F. Yale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.‐F. Yale more than expected).
Fields of papers citing papers by J.‐F. Yale
This network shows the impact of papers produced by J.‐F. Yale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.‐F. Yale. The network helps show where J.‐F. Yale may publish in the future.
Co-authors
The 25 scholars most cited alongside J.‐F. Yale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease Hit paper breakdown → | 2013 | 421 |
| 2 | 1998 clinical practice guidelines for the management of diabetes in Canada | 1998 | 307 |
| 3 | 2014 | 225 | |
| 4 | 2006 | 155 | |
| 5 | 2000 | 108 | |
| 6 | 2012 | 99 | |
| 7 | 2002 | 84 | |
| 8 | 1985 | 59 | |
| 9 | 2005 | 56 | |
| 10 | Altered immunity and diabetes in the BB rat. | 1984 | 48 |
| 11 | 2012 | 44 | |
| 12 | 2012 | 35 | |
| 13 | 1999 | 34 | |
| 14 | 2018 | 28 | |
| 15 | 2018 | 20 | |
| 16 | 2018 | 16 | |
| 17 | 1985 | 12 | |
| 18 | 1987 | 3 | |
| 19 | 2023 | 1 |
About J.‐F. Yale
J.‐F. Yale is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Surgery, Molecular Biology and Pharmacology, having authored 19 papers that have together received 1.8k indexed citations. Recurring topics across this work include Diabetes Management and Research (6 papers), Diabetes and associated disorders (4 papers), Diabetes Treatment and Management (4 papers), Pancreatic function and diabetes (2 papers), Adolescent and Pediatric Healthcare (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper), Clinical practice guidelines implementation (1 paper) and Diabetes Management and Education (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Nephrology (107 citations), Transplantation (31 citations), Pharmacology (140 citations) and Obstetrics and Gynecology (54 citations). J.‐F. Yale has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Hertzel C. Gerstein, Ewa Wajs, Dennis K. Yue, Elias David‐Neto, Keith Usiskin, Bertrand Cariou, Gary Meininger, George L. Bakris, Liwen Xi and Lawrence A. Leiter. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetic Medicine, Diabetes, Diabetes & Metabolism and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.